Showing results (3131-3140 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 2, 2024
NitraTh epitope-based neoantigen vaccines for effective tumor immunotherapyWanli Zhang, Xupeiyao Shi, Shitong Huang, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
HLA-G neo-expression modifies genetic programs governing tumor cell linesDiana Tronik-Le Roux, Marina Daouya, Isabelle Poras, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patientsJiawen Yang, Yurong Chen, Xiuyuan Zhang, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical dataPatrick Reimann, Ilektra-Antonia Mavroeidi, Jonathan Burghofer, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trialKazuma Sakura, Muneyoshi Kuroyama, Yasushi Shintani, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasisJens Blobner, Laura Dengler, Constantin Eberle, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2024
Disruptions in antigen processing and presentation machinery on sarcomaSalvatore Lorenzo Renne, Laura Sama', Sonia Kumar, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2024
Recent clinical researches and technological development in TIL therapySatoko Matsueda, Lei Chen, Hongmei Li, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunityJiawei Yue, Hui Guo, Peng Xu, et al.
Cancer Immunology, Immunotherapy : CII|March 2, 2024
Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq dataWenjun Liu, Xitu Luo, Zilang Zhang, et al.
Pageof 652